Likewise, our data demonstrated that the therapeutic potential of BP in treating AD was through regulating miRNA-29b-2-5p and consequently reducing PSEN1 expression (Figure 2 and Figure 3). This evidence concerns the gene PSEN1 and Alzheimer disease.